Hepcinat plus

**Hepcinat Plus** is a combination antiviral medication that combines two active ingredients: **Daclatasvir (60 mg)** and **Sofosbuvir (400 mg)**. This combination is primarily used for the treatment of chronic hepatitis C virus (HCV) infection. ### PRODUCT DESCRIPTION **Hepcinat Plus** is indicated for the treatment of adults with chronic hepatitis C. The combination of Daclatasvir and Sofosbuvir provides a potent antiviral effect that targets the hepatitis C virus and promotes viral clearance. ### COMPOSITION Each tablet of Hepcinat Plus contains: – **Daclatasvir** – 60 mg – **Sofosbuvir** – 400 mg – **Excipients** – (inactive ingredients used in the tablet formulation) ### MECHANISM OF ACTION – **Daclatasvir**: An NS5A inhibitor that interferes with the hepatitis C virus’s replication process and assembly, thereby disrupting the viral lifecycle. – **Sofosbuvir**: An NS5B polymerase inhibitor that prevents the virus from replicating by blocking a key enzyme needed for viral RNA synthesis. Together, these medications target different aspects of the HCV lifecycle, leading to a reduction in viral load and a higher likelihood of achieving a sustained virologic response (SVR). ### DOSAGE – **Recommended Dose**: One tablet (60 mg Daclatasvir and 400 mg Sofosbuvir) once daily. – It should be taken orally, with or without food, as prescribed by a healthcare provider. ### USES Hepcinat Plus is indicated for: – The treatment of chronic hepatitis C in adults, often effective across various HCV genotypes, especially in patients without decompensated cirrhosis. ### SIDE EFFECTS Common side effects of Hepcinat Plus may include: – Fatigue – Headache – Nausea – Insomnia – Diarrhea – Rash Serious side effects may occur rarely and can include liver function abnormalities, severe allergic reactions, or changes in mood and behavior. Patients should report any unusual symptoms to their healthcare provider promptly. ### IMPORTANT NOTE – Hepcinat Plus should be part of a comprehensive treatment plan and should not be used in isolation. – It is critical for patients to attend follow-up appointments and receive routine tests to monitor liver function and the effectiveness of the treatment. ### RECOMMENDATION – Patients should strictly adhere to the prescribed dosage and not skip or double doses. If a dose is missed, it should be taken as soon as possible, except when it’s almost time for the next scheduled dose. – Discuss any other medications being taken, including over-the-counter drugs and supplements, with a healthcare provider to avoid potential interactions. – Pregnant or breastfeeding individuals should consult their healthcare provider regarding the use of this medication. ### Disclaimer Always consult a healthcare professional for personalized medical advice, potential drug interactions, and adjustments specific to individual medical needs before initiating treatment with Hepcinat Plus.